financetom
BKU
financetom
/
Financials
/
BKU
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
BankUnited, Inc.BKU
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
2.18B
Revenue (ttm)
958.35M
Net Income (ttm)
228.35M
Shares Out
74.75M
EPS (ttm)
3.08
PE Ratio
9.68
Forward PE
9.20
Dividend
$1.24 (4.33%)
Ex-Dividend Date
Apr 11, 2025
Volume
314,326
Open
28.89
Previous Close
29.82
Day's Range
28.56 - 29.48
52-Week Range
24.34 - 44.45
Beta
1.20
Analysts
Hold
Price Target
41.55 (+42.64%)
Earnings Date
Apr 28, 2025
Description >

BankUnited, Inc. operates as the bank holding company for BankUnited, a national banking association that provides a range of banking services in the United States.

The company offers deposit products, such as checking, money market deposit, and savings accounts; certificates of deposit; and treasury, commercial payment, and cash management services.

Its loans portfolio includes commercial loans, including equipment loans, secured and unsecured lines of credit, formula-based lines of credit, owner-occupied commercial real estate term loans and lines of credit, mortgage warehouse lines, capital call lines, letters of credit, commercial credit cards, small business administration and U.S. department of agriculture product offerings, export-import bank financing products, trade finance, and business acquisition finance credit facilities; commercial real estate loans; residential mortgages; and other consumer loans.

The company also offers online, mobile, and telephone banking services. It operates through a network of banking centers located in Florida counties and the New York metropolitan area, as well as Dallas, Texas.

The company was formerly known as BU Financial Corporation. BankUnited, Inc. was incorporated in 2009 and is headquartered in Miami Lakes, Florida.

Latest News >
Dolby Labs to acquire GE Licensing in $429 million deal
Dolby Labs to acquire GE Licensing in $429 million deal
Jun 6, 2024
June 6 (Reuters) - Dolby Laboratories ( DLB ) said on Thursday it would acquire GE Licensing, an intellectual property licensing business primarily targeting the consumer digital media and electronics sectors, in a $429 million deal. ...
Monster Beverage Reports Preliminary Results of Common Shares Tender Offer
Monster Beverage Reports Preliminary Results of Common Shares Tender Offer
Jun 6, 2024
08:39 AM EDT, 06/06/2024 (MT Newswires) -- Monster Beverage ( MNST ) said Thursday a total of about 77.4 million of its common shares were validly tendered and not validly withdrawn at $53 apiece under its modified Dutch auction tender offer. Additionally, under notice of guaranteed delivery, roughly 41.6 million of the company's shares were tendered, Monster Beverage ( MNST...
Vista Outdoor Surges As MNC Capital Ups The Ante With Sweetened Bid: Details
Vista Outdoor Surges As MNC Capital Ups The Ante With Sweetened Bid: Details
Jun 6, 2024
Vista Outdoor Inc. ( VSTO ) shares are trading higher after MNC Capital increased its offer to acquire the company for over $3.0 billion. The revised proposal of $39.50 represents a 46% premium to the VWAP from the announcement of Vista’s transaction with the Czechoslovak Group a.s. on October 16, 2023, up to the last closing price before MNC’s initial...
Sagimet Biosciences Says Potential Fatty Liver Disease Drug Meets Endpoints in Phase 2B Trial
Sagimet Biosciences Says Potential Fatty Liver Disease Drug Meets Endpoints in Phase 2B Trial
Jun 6, 2024
08:39 AM EDT, 06/06/2024 (MT Newswires) -- Sagimet Biosciences ( SGMT ) said Thursday that additional data from a phase 2b trial of denifanstat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis, or MASH, showed that the study met the primary and secondary endpoints. Denifanstat, an oral daily pill, achieved statistically significant results on primary and secondary liver biopsy endpoints in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved